Takeda Pharmaceutical Company Limited
2025–2026 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Current-version rows · memo entries excluded from net amount
Last updated .
A current recipient-party breakdown has not been published. Financial totals remain available; older party percentages are not shown.
Loading 10 contributions with dates…
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under Takeda Pharmaceutical Company Limited.
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for Takeda Pharmaceutical Company Limited. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported contributor groups, with evidence-based name-variant matching; not verified unique people · 10 per page
Showing 1–10 of 48 · largest absolute amount first
Evidence-based cluster of 2 reported identities; not a verified identity merge · BOSTON, MA, 02142 · TAKEDA · Healthcare & Pharmaceuticals · EXECUTIVE · 7 transaction rows
Reported name + ZIP cluster; not a verified identity merge · LAUREL, MD, 20707 · TAKEDA · Healthcare & Pharmaceuticals · VICE PRESIDENT · 2 transaction rows
Reported name + ZIP cluster; not a verified identity merge · WESTON, MA, 02493 · TAKEDA · Healthcare & Pharmaceuticals · PHARMA · 2 transaction rows
Reported name + ZIP cluster; not a verified identity merge · WILDWOOD, MO, 63040 · TAKEDA · Healthcare & Pharmaceuticals · DIRECTOR OF REIMBURSEMENT · 10 transaction rows
Reported name + ZIP cluster; not a verified identity merge · BOSTON, MA, 02127 · TAKEDA · Healthcare & Pharmaceuticals · LAWYER · 6 transaction rows
Evidence-based cluster of 2 reported identities; not a verified identity merge · SARATOGA SPRINGS, NY, 12866 · TAKEDA · Healthcare & Pharmaceuticals · DIRECTOR · Reported as O'ROURKE, MARK / OROURKE, MARK · 3 transaction rows
Reported name + ZIP cluster; not a verified identity merge · NEWTON, MA, 02459 · TAKEDA · Healthcare & Pharmaceuticals · PHYSICIAN · 2 transaction rows
Reported name + ZIP cluster; not a verified identity merge · NEW YORK, NY, 10021 · TAKEDA · Healthcare & Pharmaceuticals · PHYSICIAN · 2 transaction rows
Reported name + ZIP cluster; not a verified identity merge · BOSTON, MA, 02132 · TAKEDA · Healthcare & Pharmaceuticals · U.S. PUBLIC AFFAIRS · 2 transaction rows
Reported name + ZIP cluster; not a verified identity merge · CAMBRIDGE, MA, 02138 · TAKEDA · Healthcare & Pharmaceuticals · VP · 2 transaction rows
Where the contributions went · 10 per page
Showing 1–10 of 40 · largest absolute amount first
Senate campaign committee · ST CLAIR SHORES, MI · EL-SAYED, ABDUL · U.S. Senate MI 00 · 4 transaction rows
House campaign committee · WILMETTE, IL · ANDREW, PHILIP JEROME · U.S. House IL 09 · 2 transaction rows
House campaign committee · BALLWIN, MO · WELLMAN, FREDERICK PAUL · U.S. House MO 02 · 10 transaction rows
PAC with non-contribution account · CHEYENNE, WY · 4 transaction rows
Party committee (qualified) · WASHINGTON, DC · 33 transaction rows
Senate campaign committee · NEWARK, DE · COONS, CHRISTOPHER A. · U.S. Senate DE 00 · 2 transaction rows
House campaign committee · ANDOVER, MA · NGUYEN, TRAM · U.S. House MA 06 · 4 transaction rows
PAC (not qualified) · GLEN FALLS, NY · 2 transaction rows
PAC (not qualified) · ALEXANDRIA, VA · 1 transaction rows
Senate campaign committee · BATON ROUGE, LA · CASSIDY, WILLIAM M. · U.S. Senate LA 00 · 1 transaction rows
Individual transactions · 10 per page
Dates below are the FEC-reported contribution dates, not filing or import dates. These are individual contributions grouped by the reported employer field, not contributions by a company.
Largest contribution amounts first. Select Date of contribution or Amount to reverse the order.
| Date of contribution ↕ | Amount ↓ | Reported contributor / location | Recipient / filing |
|---|---|---|---|
| 2026-06-02FEC filing ↗ | $3,500 | HAMMAD, TAREKLAURELMD20707VICE PRESIDENTTAKEDA | ACTBLUEC00401224Primary (P)EARMARKED FOR ABDUL FOR U.S. SENATE (C00902668)Filing 2000535 |
| 2026-06-02FEC filing ↗ | $3,500 | HAMMAD, TAREKLAURELMD20707VICE PRESIDENTTAKEDA | ABDUL FOR U.S. SENATEC00902668Primary 2026 (P2026)* EARMARKED CONTRIBUTION: SEE BELOWFiling 2005720 · amended |
| 2025-07-15FEC filing ↗ | $3,500 | HANDLEY, ALISONWESTONMA02493PHARMATAKEDA | PHIL ANDREW FOR CONGRESSC00911024Primary 2026 (P2026)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1919707 |
| 2025-07-15FEC filing ↗ | $3,500 | HANDLEY, ALISONWESTONMA02493PHARMATAKEDA | ACTBLUEC00401224Not reportedEARMARKED FOR PHIL ANDREW FOR CONGRESS (C00911024)Filing 1953256 · amended |
| 2025-07-30FEC filing ↗ | $2,000 | KIM, JULIEBOSTONMA02116EXECUTIVETAKEDA | JOHNSON LEADERSHIP FUNDC00771246Primary (P)EARMARKED FROM WINREDFiling 1920774 |
| 2025-07-30FEC filing ↗ | $2,000 | KIM, JULIEBOSTONMA02116EXECUTIVETAKEDA | WINREDC00694323Primary (P)Filing 1942656 |
| 2026-07-19FEC filing ↗ | $1,500 | KIM, JULIEBOSTONMA02116EXECUTIVETAKEDA | ACTBLUEC00401224Primary (P)EARMARKED FOR MARK WARNER VICTORY FUND (C00895219)Filing 2009053 |
| 2025-02-20FEC filing ↗ | $1,500 | KIM, JULIECAMBRIDGEMA02142EXECUTIVETAKEDA | CHRIS COONS FOR DELAWAREC00475392Primary 2026 (P2026)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1886945 |
| 2025-02-20FEC filing ↗ | $1,500 | KIM, JULIECAMBRIDGEMA02142EXECUTIVETAKEDA | BILL CASSIDY FOR US SENATEC00543983Primary 2026 (P2026)EARMARKED FROM WINREDFiling 1904264 · amended |
| 2025-02-20FEC filing ↗ | $1,500 | KIM, JULIECAMBRIDGEMA02142EXECUTIVETAKEDA | ACTBLUEC00401224Not reportedEARMARKED FOR CHRIS COONS FOR DELEWARE (C00475392)Filing 1909062 |
Refunds remain negative. Memo-only rows are marked and are not additional money. Rows come from the latest available contribution publication.
Open full contribution table →Industry classification summary
Takeda is a globally recognized biopharmaceutical company specializing in the development and manufacture of medicines across several therapeutic areas such as oncology and neuroscience, as confirmed by the research and industry-specific profiles.
AI classification auto-approved under admin authorization
View source